ReviewDigestive diseases and sciences2017
Surgical Management of Pancreatic Cysts: A Shifting Paradigm Toward Selective Resection.
Review in Digestive diseases and sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 26 citations in OpenAlex.
- Giant Pancreatic Mucinous Cystadenoma Treated by Enucleation: A Case Report and Review of the Literature.Clinical case reports · 2026Article
- An Unusual Case of Microcystic Serous Cystadenoma in a 19-Year-Old Male Patient.HCA healthcare journal of medicine · 2024Article
- Development of a nomogram for predicting the high-risk groups of solid-pseudopapillary neoplasms of the pancreas.Frontiers in oncology · 2023Article
- Massive pancreatic serous cystadenomas raise important questions regarding surgical management of incidental pancreatic cystic lesions: a report of two cases.Journal of gastrointestinal oncology · 2022Article
- Solid Pseudopapillary Neoplasm of the Pancreas: Unfolding an Intriguing Condition.GE Portuguese journal of gastroenterology · 2022Review
- CT classification model of pancreatic serous cystic neoplasms and mucinous cystic neoplasms based on a deep neural network.Abdominal radiology (New York) · 2022Article
- Article
- Dynamic hematological changes in patients undergoing distal pancreatectomy with or without splenectomy: a population-based cohort study.BMC surgery · 2020Article
- Clinical diagnosis and management of pancreatic mucinous cystadenoma and cystadenocarcinoma: Single-center experience with 82 patients.World journal of gastrointestinal oncology · 2020Article
- Cystic lymphangioma of the pancreas: a hard diagnostic challenge between pancreatic cystic lesions-review of recent literature.Gland surgery · 2018Article
- [Branch duct intraductal papillary mucinous neoplasm - contra resection].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the widespread use of high-quality cross-sectional imaging, pancreatic cystic neoplasms are being diagnosed with increasing frequency. Clinicians are therefore asked to counsel a growing number of patients with pancreatic cysts diagnosed incidentally at an early, asymptomatic stage. Over the last two decades, accumulating knowledge on the biologic behavior of these neoplasms along with improved diagnostics through imaging and endoscopic cyst fluid analysis have allowed for a selective therapeutic approach toward these neoplasms. On one end of the management spectrum, observation is recommended for typically benign lesions (serous cystadenoma), and on the other end, upfront resection is recommended for likely malignant lesions (main duct IPMN, mucinous cystadenoma, solid pseudopapillary tumor, and cystic pancreatic neuroendocrine tumors). In between, management of premalignant lesions (branch duct IPMN) is dictated by the presence of high-risk features. In general, resection should be considered whenever the risk of malignancy is higher than the risk of the operation. This review aims to describe the evolution and current status of evidence guiding the selection of patients with pancreatic cystic neoplasms for surgical resection, along with a specific discussion on the type of resection required and expected outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.